APO Research
Talk to an analyst

APO RESEARCH · REPORT

Artificial Intelligence in Drug Discovery

Compare research editions
View pricing & licenses

Selected research

Market Analysis & Forecast

Global Artificial Intelligence in Drug Discovery Market Analysis and Forecast 2026-2032

6 January 2026211 pages

Choose your research edition.

Industry ResearchArtificial Intelligence in Drug Discovery Industry Research Report 2026142 pages · $2,950 USDIndustry Growth & TrendsGlobal Artificial Intelligence in Drug Discovery Industry Growth and Trends Forecast to 2032122 pages · $3,450 USDMarket StructureGlobal Artificial Intelligence in Drug Discovery Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032197 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Artificial Intelligence in Drug Discovery Market Outlook and Growth Opportunities 2026211 pages · $4,250 USDMarket Analysis & ForecastGlobal Artificial Intelligence in Drug Discovery Market Analysis and Forecast 2026-2032211 pages · $4,950 USD

Market perspective

The global Artificial Intelligence in Drug Discovery market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The North America market for Artificial Intelligence in Drug Discovery is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Europe market for Artificial Intelligence in Drug Discovery is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Read the full market overview

Asia-Pacific market for Artificial Intelligence in Drug Discovery is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The China market for Artificial Intelligence in Drug Discovery is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The major global companies of Artificial Intelligence in Drug Discovery include IBM, Exscientia, Google(Alphabet), Microsoft, Atomwise, Schrodinger, Aitia, Insilico Medicine and NVIDIA, etc. In 2025, the world's top three vendors accounted for approximately % of the revenue.

Report Includes

This report presents an overview of global market for Artificial Intelligence in Drug Discovery, market size. Analyses of the global market trends, with historic market revenue data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.

This report researches the key producers of Artificial Intelligence in Drug Discovery, also provides the revenue of main regions and countries. Of the upcoming market potential for Artificial Intelligence in Drug Discovery, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Artificial Intelligence in Drug Discovery revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Artificial Intelligence in Drug Discovery market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, revenue, and growth rate, from 2021 to 2032. Evaluation and forecast the market size for Artificial Intelligence in Drug Discovery revenue, projected growth trends, production technology, application and end-user industry.

Artificial Intelligence in Drug Discovery Segment by Company

IBM

Exscientia

Google(Alphabet)

Microsoft

Atomwise

Schrodinger

Aitia

Insilico Medicine

NVIDIA

XtalPi

BPGbio

Owkin

CytoReason

Deep Genomics

Cloud Pharmaceuticals

BenevolentAI

Cyclica

Verge Genomics

Valo Health

Envisagenics

Euretos

BioAge Labs

Iktos

BioSymetrics

Evaxion Biotech

Aria Pharmaceuticals, Inc

Artificial Intelligence in Drug Discovery Segment by Type

Hardware

Software

Service

Artificial Intelligence in Drug Discovery Segment by Application

Early Drug Discovery

Preclinical Phase

Clinical Phase

Regulatory Approval

Artificial Intelligence in Drug Discovery Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.

2. To present the key players, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Artificial Intelligence in Drug Discovery market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Artificial Intelligence in Drug Discovery and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in market size), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Artificial Intelligence in Drug Discovery.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Revenue of Artificial Intelligence in Drug Discovery in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.

Chapter 4: Detailed analysis of Artificial Intelligence in Drug Discovery company competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 5: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 6: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 7: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Artificial Intelligence in Drug Discovery revenue, gross margin, and recent development, etc.

Chapter 8: North America by type, by application and by country, revenue for each segment.

Chapter 9: Europe by type, by application and by country, revenue for each segment.

Chapter 10: China type, by application, revenue for each segment.

Chapter 11: Asia (excluding China) type, by application and by region, revenue for each segment.

Chapter 12: South America, Middle East and Africa by type, by application and by country, revenue for each segment.

Chapter 13: The main concluding insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Artificial Intelligence in Drug Discovery Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Table 2. Hardware Major Player Table 3. Software Major Player Table 4. Service Major Player Table 5. Global Artificial Intelligence in Drug Discovery Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Table 6. Early Drug Discovery Major Player Table 7. Preclinical Phase Major Player Table 8. Clinical Phase Major Player Table 9. Regulatory Approval Major Player Table 10. Artificial Intelligence in Drug Discovery Industry Trends Table 11. Artificial Intelligence in Drug Discovery Industry Drivers Table 12. Artificial Intelligence in Drug Discovery Industry Opportunities and Challenges Table 13. Artificial Intelligence in Drug Discovery Industry Restraints Table 14. Global Artificial Intelligence in Drug Discovery Market Size Growth Rate (CAGR) by Region (US$ Million): 2021 VS 2025 VS 2032 Table 15. Global Artificial Intelligence in Drug Discovery Market Size by Region (2021-2026) & (US$ Million) Table 16. Global Artificial Intelligence in Drug Discovery Market Share by Region (2021-2026) Table 17. Global Artificial Intelligence in Drug Discovery Market Size by Region (2027-2032) & (US$ Million) Table 18. Global Artificial Intelligence in Drug Discovery Market Share by Region (2027-2032) Table 19. Global Artificial Intelligence in Drug Discovery Revenue by Players (US$ Million) & (2021-2026) Table 20. Global Artificial Intelligence in Drug Discovery Revenue Market Share by Players (2021-2026) Table 21. Global Artificial Intelligence in Drug Discovery Key Players Ranking, 2024 VS 2025 VS 2026 Table 22. Global Artificial Intelligence in Drug Discovery Key Players Headquarters & Area Served Table 23. Global Artificial Intelligence in Drug Discovery Players, Product Type & Application Table 24. Global Artificial Intelligence in Drug Discovery Players Establishment Date Table 25. Global Players Market Concentration Ratio (CR5 and HHI) Table 26. Global Artificial Intelligence in Drug Discovery by Players Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 27. Global Artificial Intelligence in Drug Discovery Revenue by Type 2021 VS 2025 VS 2032 (US$ Million) Table 28. Global Artificial Intelligence in Drug Discovery Revenue by Type (2021-2026) & (US$ Million) Table 29. Global Artificial Intelligence in Drug Discovery Revenue by Type (2027-2032) & (US$ Million) Table 30. Global Artificial Intelligence in Drug Discovery Revenue Market Share by Type (2021-2026) Table 31. Global Artificial Intelligence in Drug Discovery Revenue Market Share by Type (2027-2032) Table 32. Global Artificial Intelligence in Drug Discovery Revenue by Application 2021 VS 2025 VS 2032 (US$ Million) Table 33. Global Artificial Intelligence in Drug Discovery Revenue by Application (2021-2026) & (US$ Million) Table 34. Global Artificial Intelligence in Drug Discovery Revenue by Application (2027-2032) & (US$ Million) Table 35. Global Artificial Intelligence in Drug Discovery Revenue Market Share by Application (2021-2026) Table 36. Global Artificial Intelligence in Drug Discovery Revenue Market Share by Application (2027-2032) Table 37. IBM Company Information Table 38. IBM Business Overview Table 39. IBM Artificial Intelligence in Drug Discovery Revenue and Gross Margin (US$ Million) & (2021-2026) Table 40. IBM Artificial Intelligence in Drug Discovery Product Portfolio Table 41. IBM Recent Development Table 42. Exscientia Company Information Table 43. Exscientia Business Overview Table 44. Exscientia Artificial Intelligence in Drug Discovery Revenue and Gross Margin (US$ Million) & (2021-2026) Table 45. Exscientia Artificial Intelligence in Drug Discovery Product Portfolio Table 46. Exscientia Recent Development Table 47. Google(Alphabet) Company Information Table 48. Google(Alphabet) Business Overview Table 49. Google(Alphabet) Artificial Intelligence in Drug Discovery Revenue and Gross Margin (US$ Million) & (2021-2026) Table 50. Google(Alphabet) Artificial Intelligence in Drug Discovery Product Portfolio Table 51. Google(Alphabet) Recent Development Table 52. Microsoft Company Information Table 53. Microsoft Business Overview Table 54. Microsoft Artificial Intelligence in Drug Discovery Revenue and Gross Margin (US$ Million) & (2021-2026) Table 55. Microsoft Artificial Intelligence in Drug Discovery Product Portfolio Table 56. Microsoft Recent Development Table 57. Atomwise Company Information Table 58. Atomwise Business Overview Table 59. Atomwise Artificial Intelligence in Drug Discovery Revenue and Gross Margin (US$ Million) & (2021-2026) Table 60. Atomwise Artificial Intelligence in Drug Discovery Product Portfolio Table 61. Atomwise Recent Development Table 62. Schrodinger Company Information Table 63. Schrodinger Business Overview Table 64. Schrodinger Artificial Intelligence in Drug Discovery Revenue and Gross Margin (US$ Million) & (2021-2026) Table 65. Schrodinger Artificial Intelligence in Drug Discovery Product Portfolio Table 66. Schrodinger Recent Development Table 67. Aitia Company Information Table 68. Aitia Business Overview Table 69. Aitia Artificial Intelligence in Drug Discovery Revenue and Gross Margin (US$ Million) & (2021-2026) Table 70. Aitia Artificial Intelligence in Drug Discovery Product Portfolio Table 71. Aitia Recent Development Table 72. Insilico Medicine Company Information Table 73. Insilico Medicine Business Overview Table 74. Insilico Medicine Artificial Intelligence in Drug Discovery Revenue and Gross Margin (US$ Million) & (2021-2026) Table 75. Insilico Medicine Artificial Intelligence in Drug Discovery Product Portfolio Table 76. Insilico Medicine Recent Development Table 77. NVIDIA Company Information Table 78. NVIDIA Business Overview Table 79. NVIDIA Artificial Intelligence in Drug Discovery Revenue and Gross Margin (US$ Million) & (2021-2026) Table 80. NVIDIA Artificial Intelligence in Drug Discovery Product Portfolio Table 81. NVIDIA Recent Development Table 82. XtalPi Company Information Table 83. XtalPi Business Overview Table 84. XtalPi Artificial Intelligence in Drug Discovery Revenue and Gross Margin (US$ Million) & (2021-2026) Table 85. XtalPi Artificial Intelligence in Drug Discovery Product Portfolio Table 86. XtalPi Recent Development Table 87. BPGbio Company Information Table 88. BPGbio Business Overview Table 89. BPGbio Artificial Intelligence in Drug Discovery Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 90. BPGbio Artificial Intelligence in Drug Discovery Product Portfolio Table 91. BPGbio Recent Development Table 92. Owkin Company Information Table 93. Owkin Business Overview Table 94. Owkin Artificial Intelligence in Drug Discovery Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 95. Owkin Artificial Intelligence in Drug Discovery Product Portfolio Table 96. Owkin Recent Development Table 97. CytoReason Company Information Table 98. CytoReason Business Overview Table 99. CytoReason Artificial Intelligence in Drug Discovery Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 100. CytoReason Artificial Intelligence in Drug Discovery Product Portfolio Table 101. CytoReason Recent Development Table 102. Deep Genomics Company Information Table 103. Deep Genomics Business Overview Table 104. Deep Genomics Artificial Intelligence in Drug Discovery Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 105. Deep Genomics Artificial Intelligence in Drug Discovery Product Portfolio Table 106. Deep Genomics Recent Development Table 107. Cloud Pharmaceuticals Company Information Table 108. Cloud Pharmaceuticals Business Overview Table 109. Cloud Pharmaceuticals Artificial Intelligence in Drug Discovery Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 110. Cloud Pharmaceuticals Artificial Intelligence in Drug Discovery Product Portfolio Table 111. Cloud Pharmaceuticals Recent Development Table 112. BenevolentAI Company Information Table 113. BenevolentAI Business Overview Table 114. BenevolentAI Artificial Intelligence in Drug Discovery Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 115. BenevolentAI Artificial Intelligence in Drug Discovery Product Portfolio Table 116. BenevolentAI Recent Development Table 117. Cyclica Company Information Table 118. Cyclica Business Overview Table 119. Cyclica Artificial Intelligence in Drug Discovery Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 120. Cyclica Artificial Intelligence in Drug Discovery Product Portfolio Table 121. Cyclica Recent Development Table 122. Verge Genomics Company Information Table 123. Verge Genomics Business Overview Table 124. Verge Genomics Artificial Intelligence in Drug Discovery Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 125. Verge Genomics Artificial Intelligence in Drug Discovery Product Portfolio Table 126. Verge Genomics Recent Development Table 127. Valo Health Company Information Table 128. Valo Health Business Overview Table 129. Valo Health Artificial Intelligence in Drug Discovery Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 130. Valo Health Artificial Intelligence in Drug Discovery Product Portfolio Table 131. Valo Health Recent Development Table 132. Envisagenics Company Information Table 133. Envisagenics Business Overview Table 134. Envisagenics Artificial Intelligence in Drug Discovery Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 135. Envisagenics Artificial Intelligence in Drug Discovery Product Portfolio Table 136. Envisagenics Recent Development Table 137. Euretos Company Information Table 138. Euretos Business Overview Table 139. Euretos Artificial Intelligence in Drug Discovery Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 140. Euretos Artificial Intelligence in Drug Discovery Product Portfolio Table 141. Euretos Recent Development Table 142. BioAge Labs Company Information Table 143. BioAge Labs Business Overview Table 144. BioAge Labs Artificial Intelligence in Drug Discovery Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 145. BioAge Labs Artificial Intelligence in Drug Discovery Product Portfolio Table 146. BioAge Labs Recent Development Table 147. Iktos Company Information Table 148. Iktos Business Overview Table 149. Iktos Artificial Intelligence in Drug Discovery Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 150. Iktos Artificial Intelligence in Drug Discovery Product Portfolio Table 151. Iktos Recent Development Table 152. BioSymetrics Company Information Table 153. BioSymetrics Business Overview Table 154. BioSymetrics Artificial Intelligence in Drug Discovery Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 155. BioSymetrics Artificial Intelligence in Drug Discovery Product Portfolio Table 156. BioSymetrics Recent Development Table 157. Evaxion Biotech Company Information Table 158. Evaxion Biotech Business Overview Table 159. Evaxion Biotech Artificial Intelligence in Drug Discovery Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 160. Evaxion Biotech Artificial Intelligence in Drug Discovery Product Portfolio Table 161. Evaxion Biotech Recent Development Table 162. Aria Pharmaceuticals, Inc Company Information Table 163. Aria Pharmaceuticals, Inc Business Overview Table 164. Aria Pharmaceuticals, Inc Artificial Intelligence in Drug Discovery Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 165. Aria Pharmaceuticals, Inc Artificial Intelligence in Drug Discovery Product Portfolio Table 166. Aria Pharmaceuticals, Inc Recent Development Table 167. North America Artificial Intelligence in Drug Discovery Revenue by Type (2021-2026) & (US$ Million) Table 168. North America Artificial Intelligence in Drug Discovery Revenue by Type (2027-2032) & (US$ Million) Table 169. North America Artificial Intelligence in Drug Discovery Revenue by Application (2021-2026) & (US$ Million) Table 170. North America Artificial Intelligence in Drug Discovery Revenue by Application (2027-2032) & (US$ Million) Table 171. North America Artificial Intelligence in Drug Discovery Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 172. North America Artificial Intelligence in Drug Discovery Revenue by Country (2021-2026) & (US$ Million) Table 173. North America Artificial Intelligence in Drug Discovery Revenue by Country (US$ Million) & (2027-2032) Table 174. Europe Artificial Intelligence in Drug Discovery Revenue by Type (2021-2026) & (US$ Million) Table 175. Europe Artificial Intelligence in Drug Discovery Revenue by Type (2027-2032) & (US$ Million) Table 176. Europe Artificial Intelligence in Drug Discovery Revenue by Application (2021-2026) & (US$ Million) Table 177. Europe Artificial Intelligence in Drug Discovery Revenue by Application (2027-2032) & (US$ Million) Table 178. Europe Artificial Intelligence in Drug Discovery Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 179. Europe Artificial Intelligence in Drug Discovery Revenue by Country (2021-2026) & (US$ Million) Table 180. Europe Artificial Intelligence in Drug Discovery Revenue by Country (US$ Million) & (2027-2032) Table 181. China Artificial Intelligence in Drug Discovery Revenue by Type (2021-2026) & (US$ Million) Table 182. China Artificial Intelligence in Drug Discovery Revenue by Type (2027-2032) & (US$ Million) Table 183. China Artificial Intelligence in Drug Discovery Revenue by Application (2021-2026) & (US$ Million) Table 184. China Artificial Intelligence in Drug Discovery Revenue by Application (2027-2032) & (US$ Million) Table 185. Asia Artificial Intelligence in Drug Discovery Revenue by Type (2021-2026) & (US$ Million) Table 186. Asia Artificial Intelligence in Drug Discovery Revenue by Type (2027-2032) & (US$ Million) Table 187. Asia Artificial Intelligence in Drug Discovery Revenue by Application (2021-2026) & (US$ Million) Table 188. Asia Artificial Intelligence in Drug Discovery Revenue by Application (2027-2032) & (US$ Million) Table 189. Asia Artificial Intelligence in Drug Discovery Revenue by Region (2021 VS 2025 VS 2032) & (US$ Million) Table 190. Asia Artificial Intelligence in Drug Discovery Revenue by Region (US$ Million) & (2021-2026) Table 191. Asia Artificial Intelligence in Drug Discovery Revenue by Region (US$ Million) & (2027-2032) Table 192. SAMEA Artificial Intelligence in Drug Discovery Revenue by Type (2021-2026) & (US$ Million) Table 193. SAMEA Artificial Intelligence in Drug Discovery Revenue by Type (2027-2032) & (US$ Million) Table 194. SAMEA Artificial Intelligence in Drug Discovery Revenue by Application (2021-2026) & (US$ Million) Table 195. SAMEA Artificial Intelligence in Drug Discovery Revenue by Application (2027-2032) & (US$ Million) Table 196. SAMEA Artificial Intelligence in Drug Discovery Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 197. SAMEA Artificial Intelligence in Drug Discovery Revenue by Country (2021-2026) & (US$ Million) Table 198. SAMEA Artificial Intelligence in Drug Discovery Revenue by Country (US$ Million) & (2027-2032) Table 199. Research Programs/Design for This Report Table 200. Authors List of This Report Table 201. Secondary Sources Table 202. Primary Sources List of Figures Figure 1. Artificial Intelligence in Drug Discovery Image Figure 2. Global Artificial Intelligence in Drug Discovery Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Artificial Intelligence in Drug Discovery Market Size Share 2021 VS 2025 VS 2032 Figure 4. Hardware Image Figure 5. Software Image Figure 6. Service Image Figure 7. Global Artificial Intelligence in Drug Discovery Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Figure 8. Global Artificial Intelligence in Drug Discovery Market Size Share 2021 VS 2025 VS 2032 Figure 9. Early Drug Discovery Image Figure 10. Preclinical Phase Image Figure 11. Clinical Phase Image Figure 12. Regulatory Approval Image Figure 13. Global Artificial Intelligence in Drug Discovery Market Size (US$ Million) & (2021-2032) Figure 14. Global Artificial Intelligence in Drug Discovery Market Size, (US$ Million), 2021 VS 2025 VS 2032 Figure 15. Global Artificial Intelligence in Drug Discovery Market Share by Region: 2021 VS 2025 VS 2032 Figure 16. Global Artificial Intelligence in Drug Discovery Players Revenue Share Top 10 and Top 5 in 2025 Figure 17. Players Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 18. Global Artificial Intelligence in Drug Discovery Revenue by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 19. Global Artificial Intelligence in Drug Discovery Revenue Market Share 2021 VS 2025 VS 2032 Figure 20. Global Artificial Intelligence in Drug Discovery Revenue Market Share by Type (2021-2032) Figure 21. Global Artificial Intelligence in Drug Discovery Revenue by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 22. Global Artificial Intelligence in Drug Discovery Revenue Market Share by Application (2021 VS 2025 VS 2032) Figure 23. Global Artificial Intelligence in Drug Discovery Revenue Market Share by Application (2021-2032) Figure 24. North America Artificial Intelligence in Drug Discovery Revenue YoY Growth (2021-2032) & (US$ Million) Figure 25. North America Artificial Intelligence in Drug Discovery Revenue Share by Type (2021-2032) Figure 26. North America Artificial Intelligence in Drug Discovery Revenue Share by Application (2021-2032) Figure 27. North America Artificial Intelligence in Drug Discovery Revenue Share by Country (2021-2032) Figure 28. United States Artificial Intelligence in Drug Discovery Revenue YoY Growth (US$ Million) & (2021-2032) Figure 29. Canada Artificial Intelligence in Drug Discovery Revenue YoY Growth (US$ Million) & (2021-2032) Figure 30. Mexico Artificial Intelligence in Drug Discovery Revenue YoY Growth (US$ Million) & (2021-2032) Figure 31. Europe Artificial Intelligence in Drug Discovery Revenue YoY Growth (2021-2032) & (US$ Million) Figure 32. Europe Artificial Intelligence in Drug Discovery Revenue Share by Type (2021-2032) Figure 33. Europe Artificial Intelligence in Drug Discovery Revenue Share by Application (2021-2032) Figure 34. Europe Artificial Intelligence in Drug Discovery Revenue Share by Country (2021-2032) Figure 35. Germany Artificial Intelligence in Drug Discovery Revenue YoY Growth (US$ Million) & (2021-2032) Figure 36. France Artificial Intelligence in Drug Discovery Revenue YoY Growth (US$ Million) & (2021-2032) Figure 37. U.K. Artificial Intelligence in Drug Discovery Revenue YoY Growth (US$ Million) & (2021-2032) Figure 38. Italy Artificial Intelligence in Drug Discovery Revenue YoY Growth (US$ Million) & (2021-2032) Figure 39. Spain Artificial Intelligence in Drug Discovery Revenue YoY Growth (US$ Million) & (2021-2032) Figure 40. Russia Artificial Intelligence in Drug Discovery Revenue YoY Growth (US$ Million) & (2021-2032) Figure 41. Netherlands Artificial Intelligence in Drug Discovery Revenue YoY Growth (US$ Million) & (2021-2032) Figure 42. Nordic Countries Artificial Intelligence in Drug Discovery Revenue YoY Growth (US$ Million) & (2021-2032) Figure 43. China Artificial Intelligence in Drug Discovery Revenue YoY Growth (2021-2032) & (US$ Million) Figure 44. China Artificial Intelligence in Drug Discovery Revenue Share by Type (2021-2032) Figure 45. China Artificial Intelligence in Drug Discovery Revenue Share by Application (2021-2032) Figure 46. Asia Artificial Intelligence in Drug Discovery Revenue YoY Growth (2021-2032) & (US$ Million) Figure 47. Asia Artificial Intelligence in Drug Discovery Revenue Share by Type (2021-2032) Figure 48. Asia Artificial Intelligence in Drug Discovery Revenue Share by Application (2021-2032) Figure 49. Asia Artificial Intelligence in Drug Discovery Revenue Share by Region (2021-2032) Figure 50. Japan Artificial Intelligence in Drug Discovery Revenue YoY Growth (US$ Million) & (2021-2032) Figure 51. South Korea Artificial Intelligence in Drug Discovery Revenue YoY Growth (US$ Million) & (2021-2032) Figure 52. India Artificial Intelligence in Drug Discovery Revenue YoY Growth (US$ Million) & (2021-2032) Figure 53. Australia Artificial Intelligence in Drug Discovery Revenue YoY Growth (US$ Million) & (2021-2032) Figure 54. Taiwan Artificial Intelligence in Drug Discovery Revenue YoY Growth (US$ Million) & (2021-2032) Figure 55. Southeast Asia Artificial Intelligence in Drug Discovery Revenue YoY Growth (US$ Million) & (2021-2032) Figure 56. SAMEA Artificial Intelligence in Drug Discovery Revenue YoY Growth (2021-2032) & (US$ Million) Figure 57. SAMEA Artificial Intelligence in Drug Discovery Revenue Share by Type (2021-2032) Figure 58. SAMEA Artificial Intelligence in Drug Discovery Revenue Share by Application (2021-2032) Figure 59. SAMEA Artificial Intelligence in Drug Discovery Revenue Share by Country (2021-2032) Figure 60. Brazil Artificial Intelligence in Drug Discovery Revenue YoY Growth (US$ Million) & (2021-2032) Figure 61. Argentina Artificial Intelligence in Drug Discovery Revenue YoY Growth (US$ Million) & (2021-2032) Figure 62. Chile Artificial Intelligence in Drug Discovery Revenue YoY Growth (US$ Million) & (2021-2032) Figure 63. Colombia Artificial Intelligence in Drug Discovery Revenue YoY Growth (US$ Million) & (2021-2032) Figure 64. Peru Artificial Intelligence in Drug Discovery Revenue YoY Growth (US$ Million) & (2021-2032) Figure 65. Saudi Arabia Artificial Intelligence in Drug Discovery Revenue YoY Growth (US$ Million) & (2021-2032) Figure 66. Israel Artificial Intelligence in Drug Discovery Revenue YoY Growth (US$ Million) & (2021-2032) Figure 67. UAE Artificial Intelligence in Drug Discovery Revenue YoY Growth (US$ Million) & (2021-2032) Figure 68. Turkey Artificial Intelligence in Drug Discovery Revenue YoY Growth (US$ Million) & (2021-2032) Figure 69. Iran Artificial Intelligence in Drug Discovery Revenue YoY Growth (US$ Million) & (2021-2032) Figure 70. Egypt Artificial Intelligence in Drug Discovery Revenue YoY Growth (US$ Million) & (2021-2032) Figure 71. Years Considered Figure 72. Research Process Figure 73. Key Executives Interviewed

Scope & coverage.

Types
  • Hardware
  • Software
  • Service
Applications
  • Early Drug Discovery
  • Preclinical Phase
  • Clinical Phase
  • Regulatory Approval
Companies covered
  • IBM
  • Exscientia
  • Google(Alphabet)
  • Microsoft
  • Atomwise
  • Schrodinger
  • Aitia
  • Insilico Medicine
  • NVIDIA
  • XtalPi
  • BPGbio
  • Owkin
  • CytoReason
  • Deep Genomics
  • Cloud Pharmaceuticals
  • BenevolentAI
  • Cyclica
  • Verge Genomics
  • Valo Health
  • Envisagenics
  • Euretos
  • BioAge Labs
  • Iktos
  • BioSymetrics
  • Evaxion Biotech
  • Aria Pharmaceuticals, Inc

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Artificial Intelligence in Drug Discovery Market by Type
  3. 1.2.1 Global Artificial Intelligence in Drug Discovery Market Size by Type, 2021 VS 2025 VS 2032
  4. 1.2.2 Hardware
  5. 1.2.3 Software
  6. 1.2.4 Service
  7. 1.3 Artificial Intelligence in Drug Discovery Market by Application
  8. 1.3.1 Global Artificial Intelligence in Drug Discovery Market Size by Application, 2021 VS 2025 VS 2032
  9. 1.3.2 Early Drug Discovery
  10. 1.3.3 Preclinical Phase
  11. 1.3.4 Clinical Phase
  12. 1.3.5 Regulatory Approval
  13. 1.4 Assumptions and Limitations
  14. 1.5 Study Goals and Objectives
2 Artificial Intelligence in Drug Discovery Market Dynamics
  1. 2.1 Artificial Intelligence in Drug Discovery Industry Trends
  2. 2.2 Artificial Intelligence in Drug Discovery Industry Drivers
  3. 2.3 Artificial Intelligence in Drug Discovery Industry Opportunities and Challenges
  4. 2.4 Artificial Intelligence in Drug Discovery Industry Restraints
3 Global Growth Perspective
  1. 3.1 Global Artificial Intelligence in Drug Discovery Market Perspective (2021-2032)
  2. 3.2 Global Artificial Intelligence in Drug Discovery Growth Trends by Region
  3. 3.2.1 Global Artificial Intelligence in Drug Discovery Market Size by Region: 2021 VS 2025 VS 2032
  4. 3.2.2 Global Artificial Intelligence in Drug Discovery Market Size by Region (2021-2026)
  5. 3.2.3 Global Artificial Intelligence in Drug Discovery Market Size by Region (2027-2032)
4 Competitive Landscape by Players
  1. 4.1 Global Artificial Intelligence in Drug Discovery Revenue by Players
  2. 4.1.1 Global Artificial Intelligence in Drug Discovery Revenue by Players (2021-2026)
  3. 4.1.2 Global Artificial Intelligence in Drug Discovery Revenue Market Share by Players (2021-2026)
  4. 4.1.3 Global Artificial Intelligence in Drug Discovery Players Revenue Share Top 10 and Top 5 in 2025
  5. 4.2 Global Artificial Intelligence in Drug Discovery Key Players Ranking, 2024 VS 2025 VS 2026
  6. 4.3 Global Artificial Intelligence in Drug Discovery Key Players Headquarters & Area Served
  7. 4.4 Global Artificial Intelligence in Drug Discovery Players, Product Type & Application
  8. 4.5 Global Artificial Intelligence in Drug Discovery Players Establishment Date
  9. 4.6 Market Competitive Analysis
  10. 4.6.1 Global Artificial Intelligence in Drug Discovery Market CR5 and HHI
  11. 4.6.3 2025 Artificial Intelligence in Drug Discovery Tier 1, Tier 2, and Tier 3
5 Artificial Intelligence in Drug Discovery Market Size by Type
  1. 5.1 Global Artificial Intelligence in Drug Discovery Revenue by Type (2021 VS 2025 VS 2032)
  2. 5.2 Global Artificial Intelligence in Drug Discovery Revenue by Type (2021-2032)
  3. 5.3 Global Artificial Intelligence in Drug Discovery Revenue Market Share by Type (2021-2032)
6 Artificial Intelligence in Drug Discovery Market Size by Application
  1. 6.1 Global Artificial Intelligence in Drug Discovery Revenue by Application (2021 VS 2025 VS 2032)
  2. 6.2 Global Artificial Intelligence in Drug Discovery Revenue by Application (2021-2032)
  3. 6.3 Global Artificial Intelligence in Drug Discovery Revenue Market Share by Application (2021-2032)
7 Company Profiles
  1. 7.1 IBM
  2. 7.1.1 IBM Company Information
  3. 7.1.2 IBM Business Overview
  4. 7.1.3 IBM Artificial Intelligence in Drug Discovery Revenue and Gross Margin (2021-2026)
  5. 7.1.4 IBM Artificial Intelligence in Drug Discovery Product Portfolio
  6. 7.1.5 IBM Recent Developments
  7. 7.2 Exscientia
  8. 7.2.1 Exscientia Company Information
  9. 7.2.2 Exscientia Business Overview
  10. 7.2.3 Exscientia Artificial Intelligence in Drug Discovery Revenue and Gross Margin (2021-2026)
  11. 7.2.4 Exscientia Artificial Intelligence in Drug Discovery Product Portfolio
  12. 7.2.5 Exscientia Recent Developments
  13. 7.3 Google(Alphabet)
  14. 7.3.1 Google(Alphabet) Company Information
  15. 7.3.2 Google(Alphabet) Business Overview
  16. 7.3.3 Google(Alphabet) Artificial Intelligence in Drug Discovery Revenue and Gross Margin (2021-2026)
  17. 7.3.4 Google(Alphabet) Artificial Intelligence in Drug Discovery Product Portfolio
  18. 7.3.5 Google(Alphabet) Recent Developments
  19. 7.4 Microsoft
  20. 7.4.1 Microsoft Company Information
  21. 7.4.2 Microsoft Business Overview
  22. 7.4.3 Microsoft Artificial Intelligence in Drug Discovery Revenue and Gross Margin (2021-2026)
  23. 7.4.4 Microsoft Artificial Intelligence in Drug Discovery Product Portfolio
  24. 7.4.5 Microsoft Recent Developments
  25. 7.5 Atomwise
  26. 7.5.1 Atomwise Company Information
  27. 7.5.2 Atomwise Business Overview
  28. 7.5.3 Atomwise Artificial Intelligence in Drug Discovery Revenue and Gross Margin (2021-2026)
  29. 7.5.4 Atomwise Artificial Intelligence in Drug Discovery Product Portfolio
  30. 7.5.5 Atomwise Recent Developments
  31. 7.6 Schrodinger
  32. 7.6.1 Schrodinger Company Information
  33. 7.6.2 Schrodinger Business Overview
  34. 7.6.3 Schrodinger Artificial Intelligence in Drug Discovery Revenue and Gross Margin (2021-2026)
  35. 7.6.4 Schrodinger Artificial Intelligence in Drug Discovery Product Portfolio
  36. 7.6.5 Schrodinger Recent Developments
  37. 7.7 Aitia
  38. 7.7.1 Aitia Company Information
  39. 7.7.2 Aitia Business Overview
  40. 7.7.3 Aitia Artificial Intelligence in Drug Discovery Revenue and Gross Margin (2021-2026)
  41. 7.7.4 Aitia Artificial Intelligence in Drug Discovery Product Portfolio
  42. 7.7.5 Aitia Recent Developments
  43. 7.8 Insilico Medicine
  44. 7.8.1 Insilico Medicine Company Information
  45. 7.8.2 Insilico Medicine Business Overview
  46. 7.8.3 Insilico Medicine Artificial Intelligence in Drug Discovery Revenue and Gross Margin (2021-2026)
  47. 7.8.4 Insilico Medicine Artificial Intelligence in Drug Discovery Product Portfolio
  48. 7.8.5 Insilico Medicine Recent Developments
  49. 7.9 NVIDIA
  50. 7.9.1 NVIDIA Company Information
  51. 7.9.2 NVIDIA Business Overview
  52. 7.9.3 NVIDIA Artificial Intelligence in Drug Discovery Revenue and Gross Margin (2021-2026)
  53. 7.9.4 NVIDIA Artificial Intelligence in Drug Discovery Product Portfolio
  54. 7.9.5 NVIDIA Recent Developments
  55. 7.10 XtalPi
  56. 7.10.1 XtalPi Company Information
  57. 7.10.2 XtalPi Business Overview
  58. 7.10.3 XtalPi Artificial Intelligence in Drug Discovery Revenue and Gross Margin (2021-2026)
  59. 7.10.4 XtalPi Artificial Intelligence in Drug Discovery Product Portfolio
  60. 7.10.5 XtalPi Recent Developments
  61. 7.11 BPGbio
  62. 7.11.1 BPGbio Company Information
  63. 7.11.2 BPGbio Business Overview
  64. 7.11.3 BPGbio Artificial Intelligence in Drug Discovery Revenue and Gross Margin (2021-2026)
  65. 7.11.4 BPGbio Artificial Intelligence in Drug Discovery Product Portfolio
  66. 7.11.5 BPGbio Recent Developments
  67. 7.12 Owkin
  68. 7.12.1 Owkin Company Information
  69. 7.12.2 Owkin Business Overview
  70. 7.12.3 Owkin Artificial Intelligence in Drug Discovery Revenue and Gross Margin (2021-2026)
  71. 7.12.4 Owkin Artificial Intelligence in Drug Discovery Product Portfolio
  72. 7.12.5 Owkin Recent Developments
  73. 7.13 CytoReason
  74. 7.13.1 CytoReason Company Information
  75. 7.13.2 CytoReason Business Overview
  76. 7.13.3 CytoReason Artificial Intelligence in Drug Discovery Revenue and Gross Margin (2021-2026)
  77. 7.13.4 CytoReason Artificial Intelligence in Drug Discovery Product Portfolio
  78. 7.13.5 CytoReason Recent Developments
  79. 7.14 Deep Genomics
  80. 7.14.1 Deep Genomics Company Information
  81. 7.14.2 Deep Genomics Business Overview
  82. 7.14.3 Deep Genomics Artificial Intelligence in Drug Discovery Revenue and Gross Margin (2021-2026)
  83. 7.14.4 Deep Genomics Artificial Intelligence in Drug Discovery Product Portfolio
  84. 7.14.5 Deep Genomics Recent Developments
  85. 7.15 Cloud Pharmaceuticals
  86. 7.15.1 Cloud Pharmaceuticals Company Information
  87. 7.15.2 Cloud Pharmaceuticals Business Overview
  88. 7.15.3 Cloud Pharmaceuticals Artificial Intelligence in Drug Discovery Revenue and Gross Margin (2021-2026)
  89. 7.15.4 Cloud Pharmaceuticals Artificial Intelligence in Drug Discovery Product Portfolio
  90. 7.15.5 Cloud Pharmaceuticals Recent Developments
  91. 7.16 BenevolentAI
  92. 7.16.1 BenevolentAI Company Information
  93. 7.16.2 BenevolentAI Business Overview
  94. 7.16.3 BenevolentAI Artificial Intelligence in Drug Discovery Revenue and Gross Margin (2021-2026)
  95. 7.16.4 BenevolentAI Artificial Intelligence in Drug Discovery Product Portfolio
  96. 7.16.5 BenevolentAI Recent Developments
  97. 7.17 Cyclica
  98. 7.17.1 Cyclica Company Information
  99. 7.17.2 Cyclica Business Overview
  100. 7.17.3 Cyclica Artificial Intelligence in Drug Discovery Revenue and Gross Margin (2021-2026)
  101. 7.17.4 Cyclica Artificial Intelligence in Drug Discovery Product Portfolio
  102. 7.17.5 Cyclica Recent Developments
  103. 7.18 Verge Genomics
  104. 7.18.1 Verge Genomics Company Information
  105. 7.18.2 Verge Genomics Business Overview
  106. 7.18.3 Verge Genomics Artificial Intelligence in Drug Discovery Revenue and Gross Margin (2021-2026)
  107. 7.18.4 Verge Genomics Artificial Intelligence in Drug Discovery Product Portfolio
  108. 7.18.5 Verge Genomics Recent Developments
  109. 7.19 Valo Health
  110. 7.19.1 Valo Health Company Information
  111. 7.19.2 Valo Health Business Overview
  112. 7.19.3 Valo Health Artificial Intelligence in Drug Discovery Revenue and Gross Margin (2021-2026)
  113. 7.19.4 Valo Health Artificial Intelligence in Drug Discovery Product Portfolio
  114. 7.19.5 Valo Health Recent Developments
  115. 7.20 Envisagenics
  116. 7.20.1 Envisagenics Company Information
  117. 7.20.2 Envisagenics Business Overview
  118. 7.20.3 Envisagenics Artificial Intelligence in Drug Discovery Revenue and Gross Margin (2021-2026)
  119. 7.20.4 Envisagenics Artificial Intelligence in Drug Discovery Product Portfolio
  120. 7.20.5 Envisagenics Recent Developments
  121. 7.21 Euretos
  122. 7.21.1 Euretos Company Information
  123. 7.21.2 Euretos Business Overview
  124. 7.21.3 Euretos Artificial Intelligence in Drug Discovery Revenue and Gross Margin (2021-2026)
  125. 7.21.4 Euretos Artificial Intelligence in Drug Discovery Product Portfolio
  126. 7.21.5 Euretos Recent Developments
  127. 7.22 BioAge Labs
  128. 7.22.1 BioAge Labs Company Information
  129. 7.22.2 BioAge Labs Business Overview
  130. 7.22.3 BioAge Labs Artificial Intelligence in Drug Discovery Revenue and Gross Margin (2021-2026)
  131. 7.22.4 BioAge Labs Artificial Intelligence in Drug Discovery Product Portfolio
  132. 7.22.5 BioAge Labs Recent Developments
  133. 7.23 Iktos
  134. 7.23.1 Iktos Company Information
  135. 7.23.2 Iktos Business Overview
  136. 7.23.3 Iktos Artificial Intelligence in Drug Discovery Revenue and Gross Margin (2021-2026)
  137. 7.23.4 Iktos Artificial Intelligence in Drug Discovery Product Portfolio
  138. 7.23.5 Iktos Recent Developments
  139. 7.24 BioSymetrics
  140. 7.24.1 BioSymetrics Company Information
  141. 7.24.2 BioSymetrics Business Overview
  142. 7.24.3 BioSymetrics Artificial Intelligence in Drug Discovery Revenue and Gross Margin (2021-2026)
  143. 7.24.4 BioSymetrics Artificial Intelligence in Drug Discovery Product Portfolio
  144. 7.24.5 BioSymetrics Recent Developments
  145. 7.25 Evaxion Biotech
  146. 7.25.1 Evaxion Biotech Company Information
  147. 7.25.2 Evaxion Biotech Business Overview
  148. 7.25.3 Evaxion Biotech Artificial Intelligence in Drug Discovery Revenue and Gross Margin (2021-2026)
  149. 7.25.4 Evaxion Biotech Artificial Intelligence in Drug Discovery Product Portfolio
  150. 7.25.5 Evaxion Biotech Recent Developments
  151. 7.26 Aria Pharmaceuticals, Inc
  152. 7.26.1 Aria Pharmaceuticals, Inc Company Information
  153. 7.26.2 Aria Pharmaceuticals, Inc Business Overview
  154. 7.26.3 Aria Pharmaceuticals, Inc Artificial Intelligence in Drug Discovery Revenue and Gross Margin (2021-2026)
  155. 7.26.4 Aria Pharmaceuticals, Inc Artificial Intelligence in Drug Discovery Product Portfolio
  156. 7.26.5 Aria Pharmaceuticals, Inc Recent Developments
8 North America
  1. 8.1 North America Artificial Intelligence in Drug Discovery Revenue (2021-2032)
  2. 8.2 North America Artificial Intelligence in Drug Discovery Revenue by Type (2021-2032)
  3. 8.2.1 North America Artificial Intelligence in Drug Discovery Revenue by Type (2021-2026)
  4. 8.2.2 North America Artificial Intelligence in Drug Discovery Revenue by Type (2027-2032)
  5. 8.3 North America Artificial Intelligence in Drug Discovery Revenue Share by Type (2021-2032)
  6. 8.4 North America Artificial Intelligence in Drug Discovery Revenue by Application (2021-2032)
  7. 8.4.1 North America Artificial Intelligence in Drug Discovery Revenue by Application (2021-2026)
  8. 8.4.2 North America Artificial Intelligence in Drug Discovery Revenue by Application (2027-2032)
  9. 8.5 North America Artificial Intelligence in Drug Discovery Revenue Share by Application (2021-2032)
  10. 8.6 North America Artificial Intelligence in Drug Discovery Revenue by Country
  11. 8.6.1 North America Artificial Intelligence in Drug Discovery Revenue by Country (2021 VS 2025 VS 2032)
  12. 8.6.2 North America Artificial Intelligence in Drug Discovery Revenue by Country (2021-2026)
  13. 8.6.3 North America Artificial Intelligence in Drug Discovery Revenue by Country (2027-2032)
  14. 8.6.4 United States
  15. 8.6.5 Canada
  16. 8.6.6 Mexico
9 Europe
  1. 9.1 Europe Artificial Intelligence in Drug Discovery Revenue (2021-2032)
  2. 9.2 Europe Artificial Intelligence in Drug Discovery Revenue by Type (2021-2032)
  3. 9.2.1 Europe Artificial Intelligence in Drug Discovery Revenue by Type (2021-2026)
  4. 9.2.2 Europe Artificial Intelligence in Drug Discovery Revenue by Type (2027-2032)
  5. 9.3 Europe Artificial Intelligence in Drug Discovery Revenue Share by Type (2021-2032)
  6. 9.4 Europe Artificial Intelligence in Drug Discovery Revenue by Application (2021-2032)
  7. 9.4.1 Europe Artificial Intelligence in Drug Discovery Revenue by Application (2021-2026)
  8. 9.4.2 Europe Artificial Intelligence in Drug Discovery Revenue by Application (2027-2032)
  9. 9.5 Europe Artificial Intelligence in Drug Discovery Revenue Share by Application (2021-2032)
  10. 9.6 Europe Artificial Intelligence in Drug Discovery Revenue by Country
  11. 9.6.1 Europe Artificial Intelligence in Drug Discovery Revenue by Country (2021 VS 2025 VS 2032)
  12. 9.6.2 Europe Artificial Intelligence in Drug Discovery Revenue by Country (2021-2026)
  13. 9.6.3 Europe Artificial Intelligence in Drug Discovery Revenue by Country (2027-2032)
  14. 9.6.4 Germany
  15. 9.6.5 France
  16. 9.6.6 U.K.
  17. 9.6.7 Italy
  18. 9.6.8 Russia
  19. 9.6.9 Spain
  20. 9.6.10 Netherlands
  21. 9.6.11 Switzerland
  22. 9.6.12 Sweden
  23. 9.6.13 Poland
10 China
  1. 10.1 China Artificial Intelligence in Drug Discovery Revenue (2021-2032)
  2. 10.2 China Artificial Intelligence in Drug Discovery Revenue by Type (2021-2032)
  3. 10.2.1 China Artificial Intelligence in Drug Discovery Revenue by Type (2021-2026)
  4. 10.2.2 China Artificial Intelligence in Drug Discovery Revenue by Type (2027-2032)
  5. 10.3 China Artificial Intelligence in Drug Discovery Revenue Share by Type (2021-2032)
  6. 10.4 China Artificial Intelligence in Drug Discovery Revenue by Application (2021-2032)
  7. 10.4.1 China Artificial Intelligence in Drug Discovery Revenue by Application (2021-2026)
  8. 10.4.2 China Artificial Intelligence in Drug Discovery Revenue by Application (2027-2032)
  9. 10.5 China Artificial Intelligence in Drug Discovery Revenue Share by Application (2021-2032)
11 Asia (Excluding China)
  1. 11.1 Asia Artificial Intelligence in Drug Discovery Revenue (2021-2032)
  2. 11.2 Asia Artificial Intelligence in Drug Discovery Revenue by Type (2021-2032)
  3. 11.2.1 Asia Artificial Intelligence in Drug Discovery Revenue by Type (2021-2026)
  4. 11.2.2 Asia Artificial Intelligence in Drug Discovery Revenue by Type (2027-2032)
  5. 11.3 Asia Artificial Intelligence in Drug Discovery Revenue Share by Type (2021-2032)
  6. 11.4 Asia Artificial Intelligence in Drug Discovery Revenue by Application (2021-2032)
  7. 11.4.1 Asia Artificial Intelligence in Drug Discovery Revenue by Application (2021-2026)
  8. 11.4.2 Asia Artificial Intelligence in Drug Discovery Revenue by Application (2027-2032)
  9. 11.5 Asia Artificial Intelligence in Drug Discovery Revenue Share by Application (2021-2032)
  10. 11.6 Asia Artificial Intelligence in Drug Discovery Revenue by Country
  11. 11.6.1 Asia Artificial Intelligence in Drug Discovery Revenue by Country (2021 VS 2025 VS 2032)
  12. 11.6.2 Asia Artificial Intelligence in Drug Discovery Revenue by Country (2021-2026)
  13. 11.6.3 Asia Artificial Intelligence in Drug Discovery Revenue by Country (2027-2032)
  14. 11.6.4 Japan
  15. 11.6.5 South Korea
  16. 11.6.6 India
  17. 11.6.7 Australia
  18. 11.6.8 Taiwan
  19. 11.6.9 Southeast Asia
12 South America, Middle East and Africa
  1. 12.1 SAMEA Artificial Intelligence in Drug Discovery Revenue (2021-2032)
  2. 12.2 SAMEA Artificial Intelligence in Drug Discovery Revenue by Type (2021-2032)
  3. 12.2.1 SAMEA Artificial Intelligence in Drug Discovery Revenue by Type (2021-2026)
  4. 12.2.2 SAMEA Artificial Intelligence in Drug Discovery Revenue by Type (2027-2032)
  5. 12.3 SAMEA Artificial Intelligence in Drug Discovery Revenue Share by Type (2021-2032)
  6. 12.4 SAMEA Artificial Intelligence in Drug Discovery Revenue by Application (2021-2032)
  7. 12.4.1 SAMEA Artificial Intelligence in Drug Discovery Revenue by Application (2021-2026)
  8. 12.4.2 SAMEA Artificial Intelligence in Drug Discovery Revenue by Application (2027-2032)
  9. 12.5 SAMEA Artificial Intelligence in Drug Discovery Revenue Share by Application (2021-2032)
  10. 12.6 SAMEA Artificial Intelligence in Drug Discovery Revenue by Country
  11. 12.6.1 SAMEA Artificial Intelligence in Drug Discovery Revenue by Country (2021 VS 2025 VS 2032)
  12. 12.6.2 SAMEA Artificial Intelligence in Drug Discovery Revenue by Country (2021-2026)
  13. 12.6.3 SAMEA Artificial Intelligence in Drug Discovery Revenue by Country (2027-2032)
  14. 12.6.4 Brazil
  15. 12.6.5 Argentina
  16. 12.6.6 Chile
  17. 12.6.7 Colombia
  18. 12.6.8 Peru
  19. 12.6.9 Saudi Arabia
  20. 12.6.10 Israel
  21. 12.6.11 UAE
  22. 12.6.12 Turkey
  23. 12.6.13 Iran
  24. 12.6.14 Egypt
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst